Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2013, Article ID 328108, 4 pages
http://dx.doi.org/10.1155/2013/328108
Case Report

Inflammatory Myofibroblastic Tumor: A Rarely Seen Submucosal Lesion of the Stomach

1Division of Medical Oncology, Department of Internal Medicine, Medical Faculty, Akdeniz University, 34098 Antalya, Turkey
2Division of Medical Oncology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University, 34098 Istanbul, Turkey
3Department of Pathology, Medical Faculty, Akdeniz University, 34098 Antalya, Turkey

Received 30 January 2013; Accepted 24 February 2013

Academic Editors: A. Goodman, J. Keller, B. I. Razzouk, and K. Tanaka

Copyright © 2013 Deniz Arslan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal benign tumor which is generally seen in children and in young adults. It is especially located in the lungs. In histopathological examination, neoplastic fusiform cells originating from a subtype of accessory immune system cells which are called fibroblastic reticulum cells are seen (Kouichi and Youichirou, 2008). Although IMT is histopathologically benign, imaging methods show its tendency for local recurrence and invasion. In most of the cases, it may not be possible to make a distinction whether it is malign or benign. Complete surgical resection is the most important treatment method. In this study, we have discussed the findings of our case having a gastric submucosal located IMT in light of the current literatures.